![Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer](https://oncodaily.com/pub/uploads/2024/09/image-5-e1725419129489.png)
Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer
Drew Moghanaki shared a post on X about a paper by Yaqi Wang et al. published in International Journal of Radiation Oncology, Biology, Physics.
“’The long-term survival of patients with CRC pulmonary oligometastases did not depend on the initial choice of the local treatment approach.’”
Authors: Yaqi Wang, MD, Xin Dong, MD, Shi Yan, MD, Bing Liu, MD, Xiang Li, MD, Shaolei Li, MD, Chao Lv, MD, Xinrun Cui, MD, Ye Tao, MD, Rong Yu, MD, Nan Wu, MD
Source: Drew Moghanaki/X
Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.
He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023